Cancer treatments may accelerate cellular aging

cancer
Credit: Pixabay/CC0 Public Domain

New research indicates that certain anti-cancer therapies may hasten cellular aging, where changes in the DNA of patients may contribute to greater inflammation and fatigue. The findings are published by Wiley early online in Cancer, a peer-reviewed journal of the American Cancer Society.

Gene activity is often adjusted during life through epigenetic changes, or physical modifications to DNA that do not involve altering the underlying DNA sequence. Some individuals may experience epigenetic age acceleration (EAA) that puts them at a higher risk of age-related conditions than other individuals of the same chronological age. Investigators recently examined EAA changes during and following cancer treatment, and they looked for a potential link between these changes and in patients with head and (HNC).

In the study of 133 patients with HNC, half of the patients experienced severe fatigue at some point. EAA was most prominent immediately after radiation therapy, when the average epigenetic age was accelerated by 4.9 years. Increased EAA was associated with elevated fatigue, and patients with severe fatigue experienced 3.1 years higher EAA than those with low fatigue. Also, patients with high levels of markers of inflammation exhibited approximately 5 years higher EAA, and inflammation appeared to account for most of the effects of EAA on fatigue.

"Our findings add to the body of evidence suggesting that long-term toxicity and possibly increased mortality incurred from anti-cancer treatments for patients with HNC may be related to increased EAA and its association with inflammation," said lead author Canhua Xiao, Ph.D., RN, FAAN, of the Emory University School of Nursing, in Atlanta. "Future studies could examine the vulnerabilities that may account for sustained high EAA, fatigue, and inflammation among patients."

The authors noted that interventions to reduce , including prior to , might benefit patients by decelerating the and subsequently reducing age-related chronic health problems such as fatigue.

An accompanying editorial stresses that chronic fatigue in patients receiving treatment for is not just a symptom; it may also play an important role in influencing patients' health.


Explore further

Inflammation from ADT may cause fatigue in prostate cancer patients

More information: "Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: a longitudinal study." Cancer (2021). DOI: 10.1002/cncr.33641
Journal information: Cancer

Provided by Wiley
Citation: Cancer treatments may accelerate cellular aging (2021, May 24) retrieved 28 July 2021 from https://medicalxpress.com/news/2021-05-cancer-treatments-cellular-aging.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments